IJRETINA - International Journal of Retina
Vol 9 No 2 (2026): International Journal of Retina (IJRetina) - INAVRS

Subthreshold Laser as Alternative Treatment for Chronic Central Serous Chorioretinopathy - A Case Series

Ferdiriva Hamzah (Retina Service, JEC Eye Hospitals and Clinics, Jakarta, Indonesia.)
Martin Hertanto (Retina Service, JEC Eye Hospitals and Clinics, Jakarta, Indonesia.)
Amalia Azrina (Parahita Clinic)



Article Info

Publish Date
22 Sep 2026

Abstract

Purpose: Subthreshold laser is a relatively new and promising therapy for chronic central serous chorioretinopathy (CSCR), particularly in regions where current mainstay therapy in the form of Indocyanine green (ICG)-based photodynamic therapy (PDT) is either too expensive or unavailable. We reported the clinical efficacy of the nondamaging subthreshold laser therapy for chronic CSCR using Endpoint Management™ system. Patients and methods: Eyes with unresolved, chronic CSCR of more than 3 months of duration were treated using PASCAL® (Topcon Medical Laser System) Streamline at 577-nm wavelength, using 200 μm retinal spot sizes. Using Endpoint Management™ Software, the laser power was first titrated with 15-ms pulses and applied over the area of serous retinal detachment and adjacent non-thickened retina using 30% pulse energy with 0.25 spot spacing. Serous retinal detachment was measured between the outer surface of the neurosensory retina and the retinal pigment epithelium (CIRRUS™ HD-OCT, Carl Zeiss Meditec, Inc). Changes in subretinal fluid (SRF) and best corrected visual acuity (BCVA) were measured over 3 months of follow-up as primary outcomes. Results: Thirteen eyes of thirteen patients (twelve male, one female) age 43 (26-63) years were included in this study. The median duration of symptoms was 12 (4-24) months. All subjects complained of metamorphopsia at first visit. Overall, the laser parameters used were 288 ± 95.36 shots and 122.50 ± 11.65mW (power). Twelve eyes (92.31%) showed a decrease of subretinal fluid, with baseline SRF value of 224 (61-375) μm and final SRF of 16 (0-154) μm. Twelve from thirteen eyes (92.31%) also recorded improved or stable BCVA [0.8 (0.5-1.0) at baseline vs. 1.0 (0.2-1.0) at the final visit] with 10 eyes (76.92%) recorded final BCVA of 1.0. Complete resolutions of SRF were found in six (46.13%) eyes. It took 12.5 (7-14) weeks to achieve complete SRF resolutions. Conclusion: Subthreshold laser therapy can improve visual acuity and enable the resolution of SRF in chronic CSCR. It may offer as an alternative to photodynamic therapy, anti-vascular endothelial growth factor, or conventional laser therapy. All of which are previously used for the treatment of chronic CSCR.

Copyrights © 2026






Journal Info

Abbrev

ijretina

Publisher

Subject

Health Professions Medicine & Pharmacology Public Health

Description

International Journal of Retina is an open access journal, accepting article in English language from all over the worlds. The aims is to provide international researchers, doctors, and clinicians in the basic and clinical fields of ophthalmology, especially retina to publish the original article, ...